Serological diagnostics of hepatitis E virus infection

Virus Research

Volumn 161, Issue 1, 2011, Pages 84-92

  Khudyakov, Yury ^a   Kamili, Saleem ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Hepatitis E; Hepatitis E virus; IgG anti HEV; IgM anti HEV; Serology

Indexed keywords

BIOLOGICAL MARKER; HEPATITIS E ANTIBODY; VIRUS PROTEIN;

ANTIGEN STRUCTURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GENETIC HETEROGENEITY; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; VIRAL GENETICS;

ANTIGENS, VIRAL; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; SEROLOGIC TESTS;

HEPATITIS E VIRUS;

EID: 80053216879     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2011.06.006     Document Type: Review

References (124)

1. Aggarwal R., Kamili S., Spelbring J., Krawczynski K. Experimental studies on subclinical hepatitis E virus infection in cynomolgus macaques. J. Infect. Dis. 2001, 184(11):1380-1385.
2. Aggarwal R., Naik S. Epidemiology of hepatitis E: current status. J. Gastroenterol. Hepatol. 2009, 24(9):1484-1493.
3. Ahmad I., Holla R.P., Jameel S. Molecular virology of hepatitis E virus. Virus Res. 2011.
4. Anderson D.A., Li F., Riddell M., Howard T., Seow H.F., Torresi J., Perry G., Sumarsidi D., Shrestha S.M., Shrestha I.L. ELISA for IgG-class antibody to hepatitis E virus based on a highly conserved, conformational epitope expressed in Escherichia coli. J. Virol. Methods 1999, 81(1-2):131-142.
5. Arankalle V.A., Lole K.S., Deshmukh T.M., Chobe L.P., Gandhe S.S. Evaluation of human (genotype 1) and swine (genotype 4)-ORF2-based ELISAs for anti-HEV IgM and IgG detection in an endemic country and search for type 4 human HEV infections. J. Viral Hepat. 2007, 14(6):435-445.
6. Avrameas S., Ternynck T. The natural autoantibodies system: between hypotheses and facts. Mol. Immunol. 1993, 30(12):1133-1142.
7. Baechlein C., Schielke A., Johne R., Ulrich R.G., Baumgaertner W., Grummer B. Prevalence of hepatitis E virus-specific antibodies in sera of German domestic pigs estimated by using different assays. Vet. Microbiol. 2010, 144(1-2):187-191.
8. Balayan M.S., Andjaparidze A.G., Savinskaya S.S., Ketiladze E.S., Braginsky D.M., Savinov A.P., Poleschuk V.F. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology 1983, 20(1):23-31.
9. Beale M.A., Tettmar K., Szypulska R., Tedder R.S., Ijaz S. Is there evidence of recent hepatitis E virus infection in English and North Welsh blood donors?. Vox Sang 2011, 100:340-342.
10. Bendall R., Ellis V., Ijaz S., Thurairajah P., Dalton H.R. Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response. J. Med. Virol. 2008, 80(1):95-101.
11. Bigaillon C., Tessé S., Lagathu G., Nicand E. Use of hepatitis E IgG avidity for diagnosis of hepatitis E infection. J. Virol. Methods. 2010, 164:127-130.
12. Bradley D.W., Krawczynski K., Cook E.H., McCaustland K.A., Humphrey C.D., Spelbring J.E., Myint H., Maynard J.E. Enterically transmitted non-A, non-B hepatitis: serial passage of disease in cynomolgus macaques and tamarins and recovery of disease-associated 27- to 34-nm viruslike particles. Proc. Natl. Acad. Sci. U.S.A. 1987, 84(17):6277-6281.
13. Bryan J.P., Tsarev S.A., Iqbal M., Ticehurst J., Emerson S., Ahmed A., Duncan J., Rafiqui A.R., Malik I.A., Purcell R.H., et al. Epidemic hepatitis E in Pakistan: patterns of serologic response and evidence that antibody to hepatitis E virus protects against disease. J. Infect. Dis. 1994, 170(3):517-521.
14. Buti M., Dominguez A., Plans P., Jardi R., Schaper M., Espunes J., Cardenosa N., Rodriguez-Frias F., Esteban R., Plasencia A., Salleras L. Community-based seroepidemiological survey of hepatitis E virus infection in Catalonia, Spain. Clin. Vaccine Immunol. 2006, 13(12):1328-1332.
15. Champsaur H., Fattal-German M., Arranhado R. Sensitivity and specificity of viral immunoglobulin M determination by indirect enzyme-linked immunosorbent assay. J. Clin. Microbiol. 1988, 26(2):328-332.
16. Chau K.H., Dawson G.J., Bile K.M., Magnius L.O., Sjogren M.H., Mushahwar I.K. Detection of IgA class antibody to hepatitis E virus in serum samples from patients with hepatitis E virus infection. J. Med. Virol. 1993, 40(4):334-338.
17. Chen H.Y., Lu Y., Howard T., Anderson D., Fong P.Y., Hu W.P., Chia C.P., Guan M. Comparison of a new immunochromatographic test to enzyme-linked immunosorbent assay for rapid detection of immunoglobulin m antibodies to hepatitis e virus in human sera. Clin. Diagn. Lab. Immunol. 2005, 12(5):593-598.
18. Christensen P.B., Engle R.E., Hjort C., Homburg K.M., Vach W., Georgsen J., Purcell R.H. Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark. Clin. Infect. Dis. 2008, 47(8):1026-1031.
19. Clayson E.T., Myint K.S., Snitbhan R., Vaughn D.W., Innis B.L., Chan L., Cheung P., Shrestha M.P. Viremia, fecal shedding, and IgM and IgG responses in patients with hepatitis E. J. Infect. Dis. 1995, 172(4):927-933.
20. Clayson E.T., Shrestha M.P., Vaughn D.W., Snitbhan R., Shrestha K.B., Longer C.F., Innis B.L. Rates of hepatitis E virus infection and disease among adolescents and adults in Kathmandu, Nepal. J. Infect. Dis. 1997, 176(3):763-766.
21. Coursaget P., Buisson Y., Depril N., le Cann P., Chabaud M., Molinie C., Roue R. Mapping of linear B cell epitopes on open reading frames 2- and 3-encoded proteins of hepatitis E virus using synthetic peptides. FEMS Microbiol. Lett. 1993, 109(2-3):251-255.
22. Dalton H.R., Thurairajah P.H., Fellows H.J., Hussaini H.S., Mitchell J., Bendall R., Banks M., Ijaz S., Teo C.G., Levine D.F. Autochthonous hepatitis E in southwest England. J. Viral Hepat. 2007, 14(5):304-309.
23. Dawson G.J., Chau K.H., Cabal C.M., Yarbough P.O., Reyes G.R., Mushahwar I.K. Solid-phase enzyme-linked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides. J. Virol. Methods 1992, 38(1):175-186.
24. Drobeniuc J., Meng J., Reuter G., Greene-Montfort T., Khudyakova N., Dimitrova Z., Kamili S., Teo C.G. Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances. Clin. Infect. Dis. 2010, 51(3):e24-e27.
25. Echevarría J.M., Fogeda M., Avellón A. Diagnosis of acute hepatitis E by antibody and molecular testing: a study on 277 suspected cases. J Clin. Virol. 2011, 59:69-71.
26. Elkady A., Tanaka Y., Kurbanov F., Hirashima N., Sugiyama M., Khan A., Kato H., Okumura A., Mizokami M. Evaluation of anti-hepatitis E virus (HEV) immunoglobulin A in a serological screening for HEV infection. J. Gastroenterol. 2007, 42(11):911-917.
27. Emerson S.U., Purcell R.H. Hepatitis E virus. Rev. Med. Virol. 2003, 13(3):145-154.
28. Emerson S.U., Anderson D., Arankalle V.A., Meng X.J., Purdy M.A., Schlauder G.G., Tsarev S.A. Virus Taxonomy. VIIIth Report of the ICTV 2004, Elsevier/Academic Press, London, 851-855.
29. Favorov M.O., Fields H.A., Purdy M.A., Yashina T.L., Aleksandrov A.G., Alter M.J., Yarasheva D.M., Bradley D.W., Margolis H.S. Serologic identification of hepatitis E virus infections in epidemic and endemic settings. J. Med. Virol. 1992, 36(4):246-250.
30. Favorov M.O., Khudyakov Y.E., Fields H.A., Khudyakova N.S., Padhye N., Alter M.J., Mast E., Polish L., Yashina T.L., Yarasheva D.M., et al. Enzyme immunoassay for the detection of antibody to hepatitis E virus based on synthetic peptides. J. Virol. Methods 1994, 46(2):237-250.
31. Favorov M.O., Khudyakov Y.E., Mast E.E., Yashina T.L., Shapiro C.N., Khudyakova N.S., Jue D.L., Onischenko G.G., Margolis H.S., Fields H.A. IgM and IgG antibodies to hepatitis E virus (HEV) detected by an enzyme immunoassay based on an HEV-specific artificial recombinant mosaic protein. J. Med. Virol. 1996, 50(1):50-58.
32. Ferguson M., Walker D., Mast E., Fields H. Report of a collaborative study to assess the suitability of a reference reagent for antibodies to hepatitis E virus. Biologicals 2002, 30(1):43-48.
33. Fogeda M., de Ory F., Avellón A., Echevarría J.M. Differential diagnosis of hepatitis E virus, cytomegalovirus and Epstein-Barr virus infection in patients with suspected hepatitis E. J Clin. Virol. 2009, 45(3):259-261.
34. Goldsmith R., Yarbough P.O., Reyes G.R., Fry K.E., Gabor K.A., Kamel M., Zakaria S., Amer S., Gaffar Y. Enzyme-linked immunosorbent assay for diagnosis of acute sporadic hepatitis E in Egyptian children. Lancet 1992, 339(8789):328-331.
35. Goto K., Ito K., Sugiura T., Ando T., Mizutani F., Miyake Y., Kawabe Y., Sugiyama K., Togari H. Prevalence of hepatitis E virus infection in Japanese children. J Pediatr. Gastroenterol. Nutr. 2006, 42(1):89-92.
36. Herremans M., Bakker J., Duizer E., Vennema H., Koopmans M.P. Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity. Clin. Vaccine Immunol. 2007, 14(5):562-568.
37. Hu W.P., Lu Y., Precioso N.A., Chen H.Y., Howard T., Anderson D., Guan M. Double-antigen enzyme-linked immunosorbent assay for detection of hepatitis E virus-specific antibodies in human or swine sera. Clin. Vaccine Immunol. 2008, 15(8):1151-1157.
38. Huang W., Zhang H., Harrison T.J., Lang S., Huang G., Wang Y. Cross-protection of hepatitis E virus genotypes 1 and 4 in rhesus macaques. J. Med. Virol. 2008, 80(5):824-832.
39. Huang W.J., Zhang H.Y., Harrison T.J., Lan H.Y., Huang G.Y., Wang Y.C. Immunogenicity and protective efficacy in rhesus monkeys of a recombinant ORF2 protein from hepatitis E virus genotype 4. Arch. Virol. 2009, 154(3):481-488.
40. Huang S., Zhang X., Jiang H., Yan Q., Ai X., Wang Y., Cai J., Jiang L., Wu T., Wang Z., Guan L., Shih J.W., Ng M.H., Zhu F., Zhang J., Xia N. Profile of acute infectious markers in sporadic hepatitis E. PloS One 2010, 5(10):e13560.
41. Husain M.M., Srivastava R., Akondy R., Aggarwal R., Jameel S., Naik S. Evidence of hepatitis E virus exposure among seronegative healthy residents of an endemic area. Intervirology 2010, 54(3):139-143.
42. Ijaz S., Vyse A.J., Morgan D., Pebody R.G., Tedder R.S., Brown D. Indigenous hepatitis E virus infection in England: more common than it seems. J. Clin. Virol. 2009, 44(4):272-276.
43. Im S.W., Zhang J.Z., Zhuang H., Che X.Y., Zhu W.F., Xu G.M., Li K., Xia N.S., Ng M.H. A bacterially expressed peptide prevents experimental infection of primates by the hepatitis E virus. Vaccine 2001, 19(27):3726-3732.
44. Innis B.L., Seriwatana J., Robinson R.A., Shrestha M.P., Yarbough P.O., Longer C.F., Scott R.M., Vaughn D.W., Myint K.S. Quantitation of immunoglobulin to hepatitis E virus by enzyme immunoassay. Clin. Diagn. Lab. Immunol. 2002, 9(3):639-648.
45. Jameel S., Zafrullah M., Ozdener M.H., Panda S.K. Expression in animal cells and characterization of the hepatitis E virus structural proteins. J. Virol. 1996, 70(1):207-216.
46. Jimenez de Oya N., Galindo I., Girones O., Duizer E., Escribano J.M., Saiz J.C. Serological immunoassay for detection of hepatitis E virus on the basis of genotype 3 open reading frame 2 recombinant proteins produced in Trichoplusia ni larvae. J. Clin. Microbiol. 2009, 47(10):3276-3282.
47. Kaur M., Hyams K.C., Purdy M.A., Krawczynski K., Ching W.M., Fry K.E., Reyes G.R., Bradley D.W., Carl M. Human linear B-cell epitopes encoded by the hepatitis E virus include determinants in the RNA-dependent RNA polymerase. Proc. Natl. Acad. Sci. U.S.A. 1992, 89(9):3855-3858.
48. Khudyakov Y.E., Favorov M.O., Khudyakova N.S., Cong M.E., Holloway B.P., Padhye N., Lambert S.B., Jue D.L., Fields H.A. Artificial mosaic protein containing antigenic epitopes of hepatitis E virus. J. Virol. 1994, 68(11):7067-7074.
49. Khudyakov Y.E., Khudyakova N.S., Fields H.A., Jue D., Starling C., Favorov M.O., Krawczynski K., Polish L., Mast E., Margolis H. Epitope mapping in proteins of hepatitis E virus. Virology 1993, 194(1):89-96.
50. Khudyakov Y.E., Lopareva E.N., Jue D.L., Crews T.K., Thyagarajan S.P., Fields H.A. Antigenic domains of the open reading frame 2-encoded protein of hepatitis E virus. J. Clin. Microbiol. 1999, 37(9):2863-2871.
51. Khudyakov Yu E., Favorov M.O., Jue D.L., Hine T.K., Fields H.A. Immunodominant antigenic regions in a structural protein of the hepatitis E virus. Virology 1994, 198(1):390-393.
52. Khudyakov Yu E., Khudyakova N.S., Jue D.L., Wells T.W., Padhya N., Fields H.A. Comparative characterization of antigenic epitopes in the immunodominant region of the protein encoded by open reading frame 3 in Burmese and Mexican strains of hepatitis E virus. J. Gen. Virol. 1994, 75(Pt 3):641-646.
53. Khuroo M.S. Seroepidemiology of a second epidemic of hepatitis E in a population that had recorded first epidemic 30 years before and has been under surveillance since then. Hepatol. Int. 2010, 4(2):494-499.
54. Khuroo M.S. Discovery of hepatitis E: the epidemic non-A, non-B hepatitis 30 years down the memory lane. Virus Res. 2011.
55. Khuroo M.S., Kamili S., Dar M.Y., Moecklii R., Jameel S. Hepatitis E and long-term antibody status. Lancet 1993, 341(8856):1355.
56. Khuroo M.S., Rustgi V.K., Dawson G.J., Mushahwar I.K., Yattoo G.N., Kamili S., Khan B.A. Spectrum of hepatitis E virus infection in India. J. Med. Virol. 1994, 43(3):281-286.
57. Krawczynski K., Bradley D.W. Enterically transmitted non-A, non-B hepatitis: identification of virus-associated antigen in experimentally infected cynomolgus macaques. J. Infect. Dis. 1989, 159(6):1042-1049.
58. Krawczynski K., Meng X.J., Rybczynska J. Pathogenetic elements of hepatitis E and animal models of HEV infection. Virus Res. 2011.
59. Kuniholm M.H., Purcell R.H., McQuillan G.M., Engle R.E., Wasley A., Nelson K.E. Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994. J. Infect. Dis. 2009, 200(1):48-56.
60. Lal S.K., Tulasiram P., Jameel S. Expression and characterization of the hepatitis E virus ORF3 protein in the methylotrophic yeast, Pichia pastoris. Gene 1997, 190(1):63-67.
61. Legrand-Abravanel F., Thevenet I., Mansuy J.M., Saune K., Vischi F., Peron J.M., Kamar N., Rostaing L., Izopet J. Good performance of immunoglobulin M assays in diagnosing genotype 3 hepatitis E virus infections. Clin. Vaccine Immunol. 2009, 16(5):772-774.
62. Li F., Riddell M.A., Seow H.F., Takeda N., Miyamura T., Anderson D.A. Recombinant subunit ORF2.1 antigen and induction of antibody against immunodominant epitopes in the hepatitis E virus capsid protein. J. Med. Virol. 2000, 60(4):379-386.
63. Li F., Torresi J., Locarnini S.A., Zhuang H., Zhu W., Guo X., Anderson D.A. Amino-terminal epitopes are exposed when full-length open reading frame 2 of hepatitis E virus is expressed in Escherichia coli, but carboxy-terminal epitopes are masked. J. Med. Virol. 1997, 52(3):289-300.
64. Li F., Zhuang H., Kolivas S., Locarnini S.A., Anderson D.A. Persistent and transient antibody responses to hepatitis E virus detected by western immunoblot using open reading frame 2 and 3 and glutathione S-transferase fusion proteins. J. Clin. Microbiol. 1994, 32(9):2060-2066.
65. Li S.W., Zhang J., Li Y.M., Ou S.H., Huang G.Y., He Z.Q., Ge S.X., Xian Y.L., Pang S.Q., Ng M.H., Xia N.S. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine 2005, 23(22):2893-2901.
66. Li T.C., Zhang J., Shinzawa H., Ishibashi M., Sata M., Mast E.E., Kim K., Miyamura T., Takeda N. Empty virus-like particle-based enzyme-linked immunosorbent assay for antibodies to hepatitis E virus. J. Med. Virol. 2000, 62(3):327-333.
67. Liang J.H., Dai X., Dong C., Meng J.H. A single amino acid substitution changes antigenicity of ORF2-encoded proteins of hepatitis E virus. Int. J. Mol. Sci. 2010, 11(8):2962-2975.
68. Lin C.C., Wu J.C., Chang T.T., Chang W.Y., Yu M.L., Tam A.W., Wang S.C., Huang Y.H., Chang F.Y., Lee S.D. Diagnostic value of immunoglobulin G (IgG) and IgM anti-hepatitis E virus (HEV) tests based on HEV RNA in an area where hepatitis E is not endemic. J. Clin. Microbiol. 2000, 38(11):3915-3918.
69. Ma H., Song X., Li Z., Harrison T.J., Zhang H., Huang W., Hao W., Kong W., Wang Y. Varying abilities of recombinant polypeptides from different regions of hepatitis E virus ORF2 and ORF3 to detect anti-HEV immunoglobulin M. J. Med. Virol. 2009, 81(6):1052-1061.
70. Ma Y., Lin S.Q., Gao Y., Li M., Luo W.X., Zhang J., Xia N.S. Expression of ORF2 partial gene of hepatitis E virus in tomatoes and immunoactivity of expression products. World J. Gastroenterol. 2003, 9(10):2211-2215.
71. Mansuy J.M., Legrand-Abravanel F., Calot J.P., Peron J.M., Alric L., Agudo S., Rech H., Destruel F., Izopet J. High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France. J. Med. Virol. 2008, 80(2):289-293.
72. Mast E.E., Alter M.J., Holland P.V., Purcell R.H. Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E Virus Antibody Serum Panel Evaluation Group. Hepatology 1998, 27(3):857-861.
73. Meky F.A., Stoszek S.K., Abdel-Hamid M., Selim S., Abdel-Wahab A., Mikhail N., El-Kafrawy S., El-Daly M., Abdel-Aziz F., Sharaf S., Mohamed M.K., Engle R.E., Emerson S.U., Purcell R.H., Fix A.D., Strickland G.T. Active surveillance for acute viral hepatitis in rural villages in the Nile delta. Clin. Infect. Dis. 2006, 42:628-633.
74. Meng J., Dai X., Chang J.C., Lopareva E., Pillot J., Fields H.A., Khudyakov Y.E. Identification and characterization of the neutralization epitope(s) of the hepatitis E virus. Virology 2001, 288(2):203-211.
75. Meng J., Pillot J., Dai X., Fields H.A., Khudyakov Y.E. Neutralization of different geographic strains of the hepatitis E virus with anti-hepatitis E virus-positive serum samples obtained from different sources. Virology 1998, 249(2):316-324.
76. Meng X.J. Hepatitis E virus: animal reservoirs and zoonotic risk. Vet. Microbiol. 2010, 140(3-4):256-265.
77. Miyamura T. Hepatitis E virus infection in developed countries. Virus Res. 2011.
78. Mushahwar I.K. Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology and prevention. J. Med. Virol. 2008, 80:646-658.
79. Myint K.S., Endy T.P., Gibbons R.V., Laras K., Mammen M.P., Sedyaningsih E.R., Seriwatana J., Glass J.S., Narupiti S., Corwin A.L. Evaluation of diagnostic assays for hepatitis E virus in outbreak settings. J. Clin. Microbiol. 2006, 44(4):1581-1583.
80. Myint K.S., Endy T.P., Shrestha M.P., Shrestha S.K., Vaughn D.W., Innis B.L., Gibbons R.V., Kuschner R.A., Seriwatana J., Scott R.M. Hepatitis E antibody kinetics in Nepalese patients. Trans. R. Soc. Trop. Med. Hyg. 2006, 100(10):938-941.
81. Myint K.S., Guan M., Chen H.Y., Lu Y., Anderson D., Howard T., Noedl H., Mammen M.P. Evaluation of a new rapid immunochromatographic assay for serodiagnosis of acute hepatitis E infection. Am. J. Trop. Med. Hyg. 2005, 73(5):942-946.
82. Naot Y., Remington J.S. An enzyme-linked immunosorbent assay for detection of IgM antibodies to Toxoplasma gondii: use for diagnosis of acute acquired toxoplasmosis. J. Infect. Dis. 1980, 142(5):757-766.
83. Nicand E., Grandadam M., Teyssou R., Rey J.L., Buisson Y. Viraemia and faecal shedding of HEV in symptom-free carriers. Lancet 2001, 357(9249):68-69.
84. Obriadina A., Meng J.H., Ulanova T., Trinta K., Burkov A., Fields H.A., Khudyakov Y.E. A new enzyme immunoassay for the detection of antibody to hepatitis E virus. J. Gastroenterol. Hepatol. 2002, 17(Suppl. 3):S360-S364.
85. Pan J.S., Zhang K., Zhou J., Wu C., Zhuang H., Zhou Y.H. Application of truncated immunodominant polypeptide from hepatitis E virus (HEV) ORF2 in an assay to exclude nonspecific binding in detecting anti-HEV immunoglobulin M. J. Clin. Microbiol. 2010, 48(3):779-784.
86. Paul D.A., Knigge M.F., Ritter A., Gutierrez R., Pilot-Matias T., Chau K.H., Dawson G.J. Determination of hepatitis E virus seroprevalence by using recombinant fusion proteins and synthetic peptides. J. Infect. Dis. 1994, 169(4):801-806.
87. Purdy M.A., Carson D., McCaustland K.A., Bradley D.W., Beach M.J., Krawczynski K. Viral specificity of hepatitis E virus antigens identified by fluorescent antibody assay using recombinant HEV proteins. J. Med. Virol. 1994, 44(2):212-214.
88. Purdy M.A., Khudyakov Y.E. The molecular epidemiology of hepatitis E virus infection. Virus Res. 2011.
89. Purdy M.A., McCaustland K.A., Krawczynski K., Spelbring J., Reyes G.R., Bradley D.W. Preliminary evidence that a trpE-HEV fusion protein protects cynomolgus macaques against challenge with wild-type hepatitis E virus (HEV). J. Med. Virol. 1993, 41(1):90-94.
90. Purdy M.A., McCaustland K.A., Krawczynski K., Tam A., Beach M.J., Tassopoulos N.C., Reyes G.R., Bradley D.W. Expression of a hepatitis E virus (HEV)-trpE fusion protein containing epitopes recognized by antibodies in sera from human cases and experimentally infected primates. Arch. Virol. 1992, 123(3-4):335-349.
91. Qi Z., Cui D., Pan W., Yu C., Song Y., Cui H., Arima T. Synthesis and application of hepatitis E virus peptides to diagnosis. J. Virol. Methods 1995, 55(1):55-66.
92. Riddell M.A., Li F., Anderson D.A. Identification of immunodominant and conformational epitopes in the capsid protein of hepatitis E virus by using monoclonal antibodies. J. Virol. 2000, 74(17):8011-8017.
93. Robinson R.A., Burgess W.H., Emerson S.U., Leibowitz R.S., Sosnovtseva S.A., Tsarev S., Purcell R.H. Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells. Protein Expr. Purif. 1998, 12(1):75-84.
94. Sanford B.J., Dryman B.A., Huang Y.W., Feagins A.R., Leroith T., Meng X.J. Prior infection of pigs with a genotype 3 swine hepatitis E virus (HEV) protects against subsequent challenges with homologous and heterologous genotypes 3 and 4 human HEV. Virus Res. 2011.
95. Schofield D.J., Glamann J., Emerson S.U., Purcell R.H. Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein. J. Virol. 2000, 74(12):5548-5555.
96. Seriwatana J., Shrestha M.P., Scott R.M., Tsarev S.A., Vaughn D.W., Myint K.S., Innis B.L. Clinical and epidemiological relevance of quantitating hepatitis E virus-specific immunoglobulin M. Clin. Diagn. Lab. Immunol. 2002, 9(5):1072-1078.
97. Srinivasappa J., Saegusa J., Prabhakar B.S., Gentry M.K., Buchmeier M.J., Wiktor T.J., Koprowski H., Oldstone M.B., Notkins A.L. Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues. J. Virol. 1986, 57(1):397-401.
98. Takahashi M., Kusakai S., Mizuo H., Suzuki K., Fujimura K., Masuko K., Sugai Y., Aikawa T., Nishizawa T., Okamoto H. Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) is highly specific for diagnosis of acute HEV infection. J. Clin. Microbiol. 2005, 43(1):49-56.
99. Takahashi M., Nishizawa T., Tanaka T., Tsatsralt-Od B., Inoue J., Okamoto H. Correlation between positivity for immunoglobulin A antibodies and viraemia of swine hepatitis E virus observed among farm pigs in Japan. J. Gen. Virol. 2005, 86(Pt 6):1807-1813.
100. Tam A.W., Smith M.M., Guerra M.E., Huang C.C., Bradley D.W., Fry K.E., Reyes G.R. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 1991, 185(1):120-131.
101. Tanaka E., Matsumoto A., Takeda N., Li T.C., Umemura T., Yoshizawa K., Miyakawa Y., Miyamura T., Kiyosawa K. Age-specific antibody to hepatitis E virus has remained constant during the past 20 years in Japan. J. Viral Hepat. 2005, 12(4):439-442.
102. Teo C.G. Hepatitis E indigenous to economically developed countries: to what extent a zoonosis?. Curr. Opin. Infect. Dis. 2006, 19(5):460-466.
103. Teshale E.H., Howard C.M., Grytdal S.P., Handzel T.R., Barry V., Kamili S., Drobeniuc J., Okware S., Downing R., Tappero J.W., Bakamutumaho B., Teo C.G., Ward J.W., Holmberg S.D., Hu D.J. Hepatitis E epidemic, Uganda. Emerg. Infect. Dis. 2010, 16(1):126-129.
104. Thomas D.L., Yarbough P.O., Vlahov D., Tsarev S.A., Nelson K.E., Saah A.J., Purcell R.H. Seroreactivity to hepatitis E virus in areas where the disease is not endemic. J. Clin. Microbiol. 1997, 35(5):1244-1247.
105. Tokita H., Harada H., Gotanda Y., Takahashi M., Nishizawa T., Okamoto H. Molecular and serological characterization of sporadic acute hepatitis E in a Japanese patient infected with a genotype III hepatitis E virus in 1993. J. Gen. Virol. 2003, 84(Pt 2):421-427.
106. Tsarev S.A., Tsareva T.S., Emerson S.U., Kapikian A.Z., Ticehurst J., London W., Purcell R.H. ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primates. J. Infect. Dis. 1993, 168(2):369-378.
107. Tuuminen T., Seppanen H., Pitkanen E.M., Palomaki P., Kapyaho K. Improvement of immunoglobulin M capture immunoassay specificity: toxoplasma antibody detection method as a model. J. Clin. Microbiol. 1999, 37(1):270-273.
108. Ulanova T.I., Obriadina A.P., Talekar G., Burkov A.N., Fields H.A., Khudyakov Y.E. A new artificial antigen of the hepatitis E virus. J. Immunoassay Immunochem. 2009, 30(1):18-39.
109. Wang Y., Zhang H., Li Z., Gu W., Lan H., Hao W., Ling R., Li H., Harrison T.J. Detection of sporadic cases of hepatitis E virus (HEV) infection in China using immunoassays based on recombinant open reading frame 2 and 3 polypeptides from HEV genotype 4. J. Clin. Microbiol. 2001, 39(12):4370-4379.
110. Wedemeyer H., Pischke S. Hepatitis: Hepatitis E vaccination - is HEV 239 the breakthrough?. Nat. Rev. Gastroenterol. Hepatol. 2011, 8(1):8-10.
111. Xing L., Wang J.C., Li T.C., Yasutomi Y., Lara J., Khudyakov Y., Schofield D., Emerson S.U., Purcell R.H., Takeda N., Miyamura T., Cheng R.H. Spatial configuration of hepatitis E virus antigenic domain. J. Virol. 2011, 85(2):1117-1124.
112. Yamashita T., Mori Y., Miyazaki N., Cheng R.H., Yoshimura M., Unno H., Shima R., Moriishi K., Tsukihara T., Li T.C., Takeda N., Miyamura T., Matsuura Y. Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure. Proc. Natl. Acad. Sci. U.S.A. 2009, 106(31):12986-12991.
113. Yarbough P.O., Tam A.W., Fry K.E., Krawczynski K., McCaustland K.A., Bradley D.W., Reyes G.R. Hepatitis E virus: identification of type-common epitopes. J. Virol. 1991, 65(11):5790-5797.
114. Yu C., Engle R.E., Bryan J.P., Emerson S.U., Purcell R.H. Detection of immunoglobulin M antibodies to hepatitis E virus by class capture enzyme immunoassay. Clin. Diagn. Lab. Immunol. 2003, 10(4):579-586.
115. Zhang F., Li X., Li Z., Harrison T.J., Chong H., Qiao S., Huang W., Zhang H., Zhuang H., Wang Y. Detection of HEV antigen as a novel marker for the diagnosis of hepatitis E. J. Med. Virol. 2006, 78(11):1441-1448.
116. Zhang H., Dai X., Shan X., Meng J. Characterization of antigenic epitopes of the ORF2 protein from hepatitis E virus genotype 4. Virus Res. 2009, 142(1-2):140-143.
117. Zhang J., Gu Y., Ge S.X., Li S.W., He Z.Q., Huang G.Y., Zhuang H., Ng M.H., Xia N.S. Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein. Vaccine 2005, 23(22):2881-2892.
118. Zhang J.Z., Im S.W., Lau S.H., Chau T.N., Lai S.T., Ng S.P., Peiris M., Tse C., Ng T.K., Ng M.H. Occurrence of hepatitis E virus IgM, low avidity IgG serum antibodies, and viremia in sporadic cases of non-A, -B, and -C acute hepatitis. J. Med. Virol. 2002, 66(1):40-48.
119. Zhang J.Z., Ng M.H., Xia N.S., Lau S.H., Che X.Y., Chau T.N., Lai S.T., Im S.W. Conformational antigenic determinants generated by interactions between a bacterially expressed recombinant peptide of the hepatitis E virus structural protein. J. Med. Virol. 2001, 64(2):125-132.
120. Zhang M., Emerson S.U., Nguyen H., Engle R.E., Govindarajan S., Gerin J.L., Purcell R.H. Immunogenicity and protective efficacy of a vaccine prepared from 53kDa truncated hepatitis E virus capsid protein expressed in insect cells. Vaccine 2001, 20(5-6):853-857.
121. Zhao C., Li L., Harrison T.J., Wang Q., Song A., Fan J., Ma H., Zhang C., Wang Y. Relationships among viral diagnostic markers and markers of liver function in acute hepatitis E. J. Gastroenterol. 2009, 44(2):139-145.
122. Zhao K., Liu Q., Yu R., Li Z., Li J., Zhu H., Wu X., Tan F., Wang J., Tang X. Screening of specific diagnostic peptides of swine hepatitis E virus. Virol. J. 2009, 6:186.
123. Zhou Y.H., Purcell R.H., Emerson S.U. An ELISA for putative neutralizing antibodies to hepatitis E virus detects antibodies to genotypes 1, 2, 3, and 4. Vaccine 2004, 22(20):2578-2585.
124. Zhou Y.X., Lee M.Y., Ng J.M., Chye M.L., Yip W.K., Zee S.Y., Lam E. A truncated hepatitis E virus ORF2 protein expressed in tobacco plastids is immunogenic in mice. World J. Gastroenterol. 2006, 12(2):306-312.